Sensus Healthcare Announces Attendance at the 2012 Fall Clinical Dermatology Conference
September 24, 2012
Boca Raton, FL
Sensus Healthcare is pleased to announce its attendance at the 2012 Fall Clinical Dermatology Conference at The Encore Hotel, Las Vegas, NV on October 4 – 7, 2012. Sensus will be demonstrating its advanced superficial radiotherapy platform, the SRT-100™ for the non- invasive treatment of skin cancer. Sensus will also present an entire deck of case studies from its user base, that demonstrate the efficacy and advantages their SRT-100™ solution provides the patients, physicians, and the healthcare system.
“We are thrilled to participate in the 2012 Fall Clinical Dermatology Conference, where we have the opportunity to meet with the thought leaders in Dermatology,” stated Joe Sardano, President/CEO, Sensus Healthcare. “Our objective at these meetings is to better understand the needs of the physicians and their patients and to demonstrate how the SRT-100™ compliments and fits those needs,” continued, Steve Cohen, Senior Vice President, Strategic Initiatives.
About Sensus Healthcare:
Sensus Healthcare specializes in making proven non-melanoma skin cancer solutions more accessible to patients. Our dedicated superficial radiation therapy (SRT) systems are designed specifically to provide an alternative to surgical procedures for basal cell and squamous cell carcinomas. Our mobile, compact SRT-100™ systems are used widely by oncologists and dermatologists to bring non-melanoma skin cancer treatment to more patients in more settings.
561-922-5808 Ext. 100
The Benefits of SRT
Along with eliminating the risks for post-surgical infections and complications, the SRT-100™ provides patients and physicians with a safe and effective treatment option that offers many benefits, including:
- 95%+ cure rates that rival surgery
- No anesthesia, cutting, bleeding, stitching or pain
- No downtime or lifestyle restrictions
- Super cosmesis, no unsightly scarring
- No need for post-treatment reconstructive surgeries